Pfizer’s Viagra Case Withers In China

Law360, New York (February 5, 2007, 12:00 AM EST) -- Pfizer Inc. has suffered a blow in its bid to protect the rights to Viagra in China, with a Beijing court ruling that the drug maker can no longer use the name Wei Ge, or “mighty brother,” to market the erectile dysfunction drug because a Chinese pharmaceutical company has already registered the brand.

The Beijing No. 1 Intermediate People's Court said Guangzhou Welman, a Chinese anti-impotency drug maker, should be allowed to keep the rights to the brand name Wei Ge because it registered the name...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.